Institute for Prostate Cancer Research (IPCR) Symposium
Each year, the IPCR brings together experts in multiple field to discuss the latest breakthrough in the prevention, detection and treatment of prostate cancer. This day-long event is filled with scientific insights and projections, discussions on technology and patient care, reviews of the latest scientific innovations and landmark research projects changing how scientists view this disease.
There are currently no upcoming events. Please check back later.
Your search for "" did not match any of our events. Please try another event term or combination of terms and filters.
2024 IPCR Patient Symposium
May 11, 2024
The 2024 Symposium featured the latest findings in diagnosis and treatment, along with prevention and exercise tips.
Please click to view the talks below.
Peter Nelson, MD
Session 1 - Prostate Cancer: Risk and Interventions
Burcu Darst, PhD
Heather Greenlee, PhD
The Ozempic Weight Loss Revolution - Should Everyone Jump on the Train?
Marian Neuhouser, PhD
The Prostate Cancer Active Lifestyle Study
Jonathan Wright, MD
Question and Answer: Session 1
Wright, Neuhouser, Greenlee, Darst
Session 2 - Diagnosis, Disparities, and Survivorship
Prostate Cancer Disparities: Community Partnered Approaches to Improving Equity
Jenney Lee
Digital Pathology – AI and Cancer Diagnosis
Michael Haffner, MD, PhD
Delphine Chen, MD
Prostate Cancer Survivorship: The Road to 'Life as Usual'
Thomas Walsh, MD, & Marah Hehemann, MD
Question and Answer: Session 2
Walsh, Hehemann, Chen, Haffner, Lee
Session 3 - Advances in Treating Prostate Cancer
Clinical Trials - Investigator and Patient Perspectives
Bruce Montgomery, MD
New Approaches for Treating High Risk Prostate Cancer
Dan Lin, MD
New Treatment Approvals and Clinical Trials
Michael Schweizer, MD
Immune Therapy: Challenges and Next Steps
Jessica Hawley, MD, MS
Question and Answer: Session 3
Hawley, Schweizer, Lin, Montgomery
Peter Nelson, MD
The IPCR Symposium in June 2023 featured the latest findings in diagnosis and treatment, as well as hands-on lab activities and yoga sessions.
Please click to view the talks below.
|
Peter Nelson, MD Hereditary Prostate Cancer- Updates from GENTLeMEN Heather Cheng, MD, PhD | |
|
Yaw Nyame, MD, MS, MBA | |
The Microbiome: Impact on Cancer Risk and Treatment Dave Fredricks, MD | |
"Prehabilitation" - Faster Recovery and Better Outcomes Sarah Psutka, MD |
|
| Session I - Q&A | |
Digital Pathology - AI and Cancer Diagnosis Michael Haffner, MD, PhD | |
Radiation Therapy - Expanding the Opportunities Emily Weg, MD | |
Patient Driven Research - Your Impact John Gore, MD, MS, FACS Millions of Veterans: Impact on Prostate Cancer Bruce Montgomery, MD A Legacy Toward A Cure: Marty Chakoian and Julie Higgins New Treatment Approvals and Clinical Trials Michael Schweizer, MD Immune Therapy - Challenges and Next Steps Evan Yu, MD PSMA Therapy - Who? What? When? Delphine Chen, MD Session III - Q&A and Conference Wrap-up
|
Genetics: Risk-based Screening and Hereditary Prostate Cancer Heather H. Cheng MD, PhD | |
Earlier and Combined: New Treatment Paradigms Michael Schweizer, MD | |
Patient Centered Pathology Reports; Present and Future Microscopy | |
Polygenic Risk of Prostate Cancer Burcu Darst, PhD |
|
Radiation Therapy: Expanding the Opportunities Emily Weg, MD |
The IPCR Symposium on June 5, 2021 featured the latest research discoveries in the field of prostate cancer.
Welcome | Dr. Peter Nelson
Prostate Cancer: Disparity, Risk and Quality of Life
Diet and Prostate Cancer | Dr. Marian Neuhouser
Nutritional Supplements: Evidence and Science | Dr. Jeannette Schenk
Prostate Cancer Disparities | Dr. Yaw Nyame
Treatment Side-Effects: The Patients' Perspective | Dr. John Gore
Prostate Cancer Prevention | Dr. Dan Lin
Immunotherapy: State of the Field | Dr. John Lee
Genetics: the GENTLEMEN Study | Dr. Heather Cheng
Advances in Treating Advanced Prostate Cancer
Imaging: State of the Field | Dr. Evan Yu
Precision Treatment | Dr. Bruce Montgomery
Closing | Dr. Peter Nelson
Welcome - Dr. Peter Nelson
Session 1 - Prostate Cancer: Disparity, Risk & Quality of Life
Racial disparities in prostate cancer — time to make a difference, Dr. Ruth Etzioni
Inherited Risk: GENTleMEN, Dr. Heather Cheng
Diet and Prostate Cancer, Dr. Marian Neuhouser
Exercise Interventions and Prostate Cancer, Dr. Jonathan Wright
Enhancing Quality of Life, Dr. Niels Johnsen
Prostate Cancer: Disparity, Risk and Quality of Life Q&A
Session 2: New Imaging Biomarkers and Treatment Implications
The New Pathology (Light Sheet), Dr. Larry True & Dr. Nick Reder
PET Imaging: A Window Into New Treatment Opportunities, Dr. Manuela Matesan
Oligometastatic Prostate Cancer – Current Data/Ongoing Studies, Dr. Dan Lin
Targeted Radiation Therapy: Local Recurrence/Distant Metastasis, Dr. Jing Zeng
New Imaging Biomarkers and Treatment Implications Q & A
Session 3: Advances in Treating Advanced Prostate Cancer
Improving Survival with Combination Therapy, Dr. Michael Schweizer
Immunotherapy: State of the Field + CAR T, Dr. John Lee
Prostate Cancer Tumor Board (2 cases), Dr. Bruce Montgomery & Dr. Evan Yu
Advances in Treating Advanced Prostate Cancer Q & A
Closing Video - Dr. Peter Nelson
Our thanks to the generous supporters who helped raise $2.1 million (and still counting) in the fight against prostate cancer!
The IPCR Symposium in June 2023 featured the latest findings in diagnosis and treatment, as well as hands-on lab activities and yoga sessions.
Videos of our 2023 presentations will be available soon! Please check back to view the titles below.
|
Peter Nelson, MD Hereditary Prostate Cancer- Updates from GENTLeMEN Heather Cheng, MD, PhD | |
|
Yaw Nyame, MD, MS, MBA | |
The Microbiome: Impact on Cancer Risk and Treatment Dave Fredricks, MD | |
"Prehabilitation" - Faster Recovery and Better Outcomes Sarah Psutka, MD |
|
| Session I - Q&A | |
Digital Pathology - AI and Cancer Diagnosis Michael Haffner, MD, PhD | |
Radiation Therapy - Expanding the Opportunities Emily Weg, MD | |
Patient Driven Research - Your Impact John Gore, MD, MS, FACS Millions of Veterans: Impact on Prostate Cancer Bruce Montgomery, MD A Legacy Toward A Cure: Marty Chakoian and Julie Higgins New Treatment Approvals and Clinical Trials Michael Schweizer, MD Immune Therapy - Challenges and Next Steps Evan Yu, MD PSMA Therapy - Who? What? When? Delphine Chen, MD Session III - Q&A and Conference Wrap-up
|
Genetics: Risk-based Screening and Hereditary Prostate Cancer Heather H. Cheng MD, PhD | |
Earlier and Combined: New Treatment Paradigms Michael Schweizer, MD | |
Patient Centered Pathology Reports; Present and Future Microscopy | |
Polygenic Risk of Prostate Cancer Burcu Darst, PhD |
|
Radiation Therapy: Expanding the Opportunities Emily Weg, MD |
The IPCR Symposium on June 5, 2021 featured the latest research discoveries in the field of prostate cancer.
Welcome | Dr. Peter Nelson
Prostate Cancer: Disparity, Risk and Quality of Life
Diet and Prostate Cancer | Dr. Marian Neuhouser
Nutritional Supplements: Evidence and Science | Dr. Jeannette Schenk
Prostate Cancer Disparities | Dr. Yaw Nyame
Treatment Side-Effects: The Patients' Perspective | Dr. John Gore
Prostate Cancer Prevention | Dr. Dan Lin
Immunotherapy: State of the Field | Dr. John Lee
Genetics: the GENTLEMEN Study | Dr. Heather Cheng
Advances in Treating Advanced Prostate Cancer
Imaging: State of the Field | Dr. Evan Yu
Precision Treatment | Dr. Bruce Montgomery
Closing | Dr. Peter Nelson
Welcome - Dr. Peter Nelson
Session 1 - Prostate Cancer: Disparity, Risk & Quality of Life
Racial disparities in prostate cancer — time to make a difference, Dr. Ruth Etzioni
Inherited Risk: GENTleMEN, Dr. Heather Cheng
Diet and Prostate Cancer, Dr. Marian Neuhouser
Exercise Interventions and Prostate Cancer, Dr. Jonathan Wright
Enhancing Quality of Life, Dr. Niels Johnsen
Prostate Cancer: Disparity, Risk and Quality of Life Q&A
Session 2: New Imaging Biomarkers and Treatment Implications
The New Pathology (Light Sheet), Dr. Larry True & Dr. Nick Reder
PET Imaging: A Window Into New Treatment Opportunities, Dr. Manuela Matesan
Oligometastatic Prostate Cancer – Current Data/Ongoing Studies, Dr. Dan Lin
Targeted Radiation Therapy: Local Recurrence/Distant Metastasis, Dr. Jing Zeng
New Imaging Biomarkers and Treatment Implications Q & A
Session 3: Advances in Treating Advanced Prostate Cancer
Improving Survival with Combination Therapy, Dr. Michael Schweizer
Immunotherapy: State of the Field + CAR T, Dr. John Lee
Prostate Cancer Tumor Board (2 cases), Dr. Bruce Montgomery & Dr. Evan Yu
Advances in Treating Advanced Prostate Cancer Q & A
Closing Video - Dr. Peter Nelson
Our thanks to the generous supporters who helped raise $2.1 million (and still counting) in the fight against prostate cancer!
The IPCR Symposium in June 2023 featured the latest findings in diagnosis and treatment, as well as hands-on lab activities and yoga sessions.
Videos of our 2023 presentations will be available soon! Please check back to view the titles below.
|
Peter Nelson, MD Hereditary Prostate Cancer- Updates from GENTLeMEN Heather Cheng, MD, PhD | |
|
Yaw Nyame, MD, MS, MBA | |
The Microbiome: Impact on Cancer Risk and Treatment Dave Fredricks, MD | |
"Prehabilitation" - Faster Recovery and Better Outcomes Sarah Psutka, MD |
|
| Session I - Q&A | |
Digital Pathology - AI and Cancer Diagnosis Michael Haffner, MD, PhD | |
Radiation Therapy - Expanding the Opportunities Emily Weg, MD | |
Patient Driven Research - Your Impact John Gore, MD, MS, FACS Millions of Veterans: Impact on Prostate Cancer Bruce Montgomery, MD A Legacy Toward A Cure: Marty Chakoian and Julie Higgins New Treatment Approvals and Clinical Trials Michael Schweizer, MD Immune Therapy - Challenges and Next Steps Evan Yu, MD PSMA Therapy - Who? What? When? Delphine Chen, MD Session III - Q&A and Conference Wrap-up
|
Genetics: Risk-based Screening and Hereditary Prostate Cancer Heather H. Cheng MD, PhD | |
Earlier and Combined: New Treatment Paradigms Michael Schweizer, MD | |
Patient Centered Pathology Reports; Present and Future Microscopy | |
Polygenic Risk of Prostate Cancer Burcu Darst, PhD |
|
Radiation Therapy: Expanding the Opportunities Emily Weg, MD |
The IPCR Symposium on June 5, 2021 featured the latest research discoveries in the field of prostate cancer.
Welcome | Dr. Peter Nelson
Prostate Cancer: Disparity, Risk and Quality of Life
Diet and Prostate Cancer | Dr. Marian Neuhouser
Nutritional Supplements: Evidence and Science | Dr. Jeannette Schenk
Prostate Cancer Disparities | Dr. Yaw Nyame
Treatment Side-Effects: The Patients' Perspective | Dr. John Gore
Prostate Cancer Prevention | Dr. Dan Lin
Immunotherapy: State of the Field | Dr. John Lee
Genetics: the GENTLEMEN Study | Dr. Heather Cheng
Advances in Treating Advanced Prostate Cancer
Imaging: State of the Field | Dr. Evan Yu
Precision Treatment | Dr. Bruce Montgomery
Closing | Dr. Peter Nelson
Welcome - Dr. Peter Nelson
Session 1 - Prostate Cancer: Disparity, Risk & Quality of Life
Racial disparities in prostate cancer — time to make a difference, Dr. Ruth Etzioni
Inherited Risk: GENTleMEN, Dr. Heather Cheng
Diet and Prostate Cancer, Dr. Marian Neuhouser
Exercise Interventions and Prostate Cancer, Dr. Jonathan Wright
Enhancing Quality of Life, Dr. Niels Johnsen
Prostate Cancer: Disparity, Risk and Quality of Life Q&A
Session 2: New Imaging Biomarkers and Treatment Implications
The New Pathology (Light Sheet), Dr. Larry True & Dr. Nick Reder
PET Imaging: A Window Into New Treatment Opportunities, Dr. Manuela Matesan
Oligometastatic Prostate Cancer – Current Data/Ongoing Studies, Dr. Dan Lin
Targeted Radiation Therapy: Local Recurrence/Distant Metastasis, Dr. Jing Zeng
New Imaging Biomarkers and Treatment Implications Q & A
Session 3: Advances in Treating Advanced Prostate Cancer
Improving Survival with Combination Therapy, Dr. Michael Schweizer
Immunotherapy: State of the Field + CAR T, Dr. John Lee
Prostate Cancer Tumor Board (2 cases), Dr. Bruce Montgomery & Dr. Evan Yu
Advances in Treating Advanced Prostate Cancer Q & A
Closing Video - Dr. Peter Nelson
Our thanks to the generous supporters who helped raise $2.1 million (and still counting) in the fight against prostate cancer!
The 4th Annual IPCR Symposium was held at the Fred Hutch campus in Seattle, Wash. on Saturday, April 11, 2015.
Dr. Pete Nelson, left, introduces Dr. John Gore during the 2019 IPCR Symposium
Dr. Bruce Montgomery speaks about genome-guided therapy in advanced prostate cancer
The 4th Annual IPCR Symposium was held at the Fred Hutch campus in Seattle, Wash. on Saturday, April 11, 2015.
Dr. Pete Nelson, left, introduces Dr. John Gore during the 2019 IPCR Symposium